Where Protagonist Therapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Protagonist Therapeutics (NASDAQ:PTGX) stock, with 3 bullish and 1 somewhat bullish. The average 12-month price target is $35.5, with a high of $38.00 and a low of $28.00. The average price target has increased by 10.94% over the past month.
June 12, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Protagonist Therapeutics (PTGX) has received positive ratings from 4 analysts, with an average 12-month price target of $35.5. The target has increased by 10.94% over the past month.
The positive ratings from 4 analysts and the increase in the average 12-month price target by 10.94% over the past month indicate a bullish sentiment for Protagonist Therapeutics (PTGX) stock. This is likely to have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100